$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd

$lgnd Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000088616322000135 Filed on November 08, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$50.38M	$66.09M
YoY Change	-30.48%	1.93%
Cost Of Revenue	$21.61M	$14.15M
YoY Change	80.36%	23.65%
Gross Profit	$28.77M	$51.94M
YoY Change	-52.44%	-2.72%
Gross Profit Margin	57.1%	78.58%
Selling, General & Admin	$31.13M	$17.45M
YoY Change	75.52%	37.17%
% of Gross Profit	108.21%	33.59%
Research & Development	$9.197M	$22.04M
YoY Change	-49.59%	30.1%
% of Gross Profit	31.97%	42.43%
Depreciation & Amortization	$8.539M	$13.48M
YoY Change	-35.16%	5.93%
% of Gross Profit	29.68%	25.95%
Operating Expenses	$9.197M	$22.04M
YoY Change	-80.74%	30.1%
Operating Profit	$19.57M	$636.0K
YoY Change	53.69%	-95.95%
Interest Expense	$45.03M	$332.0K
YoY Change	-374.31%	-92.52%
% of Operating Profit	230.09%	52.2%
Other Income/Expense, Net	-$792.0K	$221.0K
YoY Change	-76.32%	-149.44%
Pretax Income	$24.14M	$857.0K
YoY Change	-443.58%	-94.38%
Income Tax	$38.67M	$453.0K
% Of Pretax Income	160.21%	52.86%
Net Earnings	-$17.49M	$404.0K
YoY Change	222.84%	-97.06%
Net Earnings / Revenue	-34.7%	0.61%
Basic Earnings Per Share		$0.02
Diluted Earnings Per Share	-$1.04	$0.02
COMMON SHARES
Basic Shares Outstanding	16.89M shares	16.89M shares
Diluted Shares Outstanding		17.13M shares

Balance Sheet

Concept	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$211.9M	$121.4M
YoY Change	-37.89%	-62.44%
Cash & Equivalents	$45.01M	$4.116M
Short-Term Investments	$166.9M	$117.3M
Other Short-Term Assets	$3.399M	$10.75M
YoY Change	-27.23%	108.22%
Inventory	$13.29M	$22.33M
Prepaid Expenses	$1.132M
Receivables	$30.42M	$65.17M
Other Receivables	$4.614M	$785.0K
Total Short-Term Assets	$263.6M	$220.4M
YoY Change	-43.28%	-48.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.48M	$33.42M
YoY Change	-39.14%	78.69%
Goodwill	$105.7M	$181.2M
YoY Change	-41.68%	-4.72%
Intangibles	$342.5M	$517.0M
YoY Change	-37.85%	-8.06%
Long-Term Investments	$0.00
YoY Change
Other Assets	$4.736M	$6.279M
YoY Change	72.78%	102.88%
Total Long-Term Assets	$499.1M	$830.2M
YoY Change	-40.08%	-1.35%
TOTAL ASSETS
Total Short-Term Assets	$263.6M	$220.4M
Total Long-Term Assets	$499.1M	$830.2M
Total Assets	$762.7M	$1.051B
YoY Change	-41.22%	-17.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.307M	$15.89M
YoY Change	-36.84%	119.65%
Accrued Expenses	$15.68M	$19.34M
YoY Change	-10.8%	58.03%
Deferred Revenue	$355.0K	$9.547M
YoY Change	-96.77%	-20.49%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$76.74M	$76.65M
YoY Change	166726.09%	170228.89%
Total Short-Term Liabilities	$98.81M	$135.2M
YoY Change	137.15%	272.6%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$21.97M	$21.95M
YoY Change	-29.09%	-19.09%
Total Long-Term Liabilities	$21.97M	$21.95M
YoY Change	-29.09%	-19.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$98.81M	$135.2M
Total Long-Term Liabilities	$21.97M	$21.95M
Total Liabilities	$165.2M	$234.3M
YoY Change	-65.33%	-49.24%
SHAREHOLDERS EQUITY
Retained Earnings	$450.9M	$468.3M
YoY Change	0.39%	3.05%
Common Stock	$17.00K	$17.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$597.5M	$816.3M
YoY Change
Total Liabilities & Shareholders Equity	$762.7M	$1.051B
YoY Change	-41.22%	-17.51%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$17.49M	$404.0K
YoY Change	222.84%	-97.06%
Depreciation, Depletion And Amortization	$8.539M	$13.48M
YoY Change	-35.16%	5.93%
Cash From Operating Activities	$53.47M	$20.49M
YoY Change	93.44%	2.32%
INVESTING ACTIVITIES
Capital Expenditures	$2.131M	-$4.329M
YoY Change	-197.08%	144.3%
Acquisitions
YoY Change
Other Investing Activities	-$5.153M	$23.50M
YoY Change	-84.63%	-242.93%
Cash From Investing Activities	-$7.284M	$19.18M
YoY Change	-79.6%	-205.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-5.298M	-40.83M
YoY Change	-227.23%	10504.94%
NET CHANGE
Cash From Operating Activities	53.47M	20.49M
Cash From Investing Activities	-7.284M	19.18M
Cash From Financing Activities	-5.298M	-40.83M
Net Change In Cash	40.89M	-1.164M
YoY Change	-1146.58%	-181.8%
FREE CASH FLOW
Cash From Operating Activities	$53.47M	$20.49M
Capital Expenditures	$2.131M	-$4.329M
Free Cash Flow	$51.34M	$24.82M
YoY Change	72.07%	13.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000886163
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33093
	dei	Entity Registrant Name EntityRegistrantName	LIGAND PHARMACEUTICALS INCORPORATED
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0160744
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3911 Sorrento Valley Boulevard, Suite 110
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
	dei	City Area Code CityAreaCode	858
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Local Phone Number LocalPhoneNumber	550-7500
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	LGND
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16893579	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4116000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19522000	usd
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	117291000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	321586000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	65168000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	85453000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	10746000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	22326000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	27326000	usd
CY2022Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	785000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	6193000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4671000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	220432000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	464751000	usd
CY2022Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	35500000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	34482000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	517025000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	551040000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	181206000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	181206000	usd
CY2022Q3	lgnd	Commercial License Rights CommercialLicenseRights	10193000	usd
CY2021Q4	lgnd	Commercial License Rights CommercialLicenseRights	10110000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33418000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20511000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	32108000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16542000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	14444000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	16207000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6279000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2741000	usd
CY2022Q3	us-gaap	Assets Assets	1050605000	usd
CY2021Q4	us-gaap	Assets Assets	1297590000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	15887000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8403000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19338000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17579000	usd
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	9703000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	usd
CY2022Q3	lgnd	Current Portion Of Liability For Contingent Value Rights CurrentPortionOfLiabilityForContingentValueRights	1773000	usd
CY2021Q4	lgnd	Current Portion Of Liability For Contingent Value Rights CurrentPortionOfLiabilityForContingentValueRights	2588000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9547000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10996000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2345000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2053000	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	48000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	46000	usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	76600000	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	135241000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	41665000	usd
CY2022Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	320717000	usd
CY2022Q3	lgnd	Liability For Contingent Value Rights LiabilityForContingentValueRights	6855000	usd
CY2021Q4	lgnd	Liability For Contingent Value Rights LiabilityForContingentValueRights	8483000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	29832000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	59095000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34893000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15494000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	5537000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9270000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	21949000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	21707000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	234307000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	476431000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16894000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16894000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16767000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16767000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	17000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1060000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	17000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	348994000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	372969000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-917000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	468347000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	449090000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	816298000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	821159000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1050605000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1297590000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66088000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64835000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169200000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	204660000	usd
CY2022Q3	us-gaap	Cost Direct Material CostDirectMaterial	14153000	usd
CY2021Q3	us-gaap	Cost Direct Material CostDirectMaterial	11446000	usd
	us-gaap	Cost Direct Material CostDirectMaterial	31213000	usd
	us-gaap	Cost Direct Material CostDirectMaterial	50192000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	11818000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	11827000	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	35455000	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	35391000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22036000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16938000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61461000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50769000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17445000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12718000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	50210000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	39747000	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
CY2021Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3800000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	37600000	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	65452000	usd
CY2021Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	49129000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	178339000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	138499000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	636000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	15706000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9139000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	66161000	usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-923000	usd
CY2021Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	1937000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-15709000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	8135000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	591000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15259000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19919000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	332000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	4439000	usd
	us-gaap	Interest Expense InterestExpense	1559000	usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	169000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1023000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	698000	usd
	us-gaap	Interest Expense InterestExpense	15154000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	885000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1886000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5465000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5516000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	221000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-447000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10780000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11837000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	857000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	54324000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	453000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1536000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4043000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8230000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	404000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	13723000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15876000	usd
	us-gaap	Net Income Loss NetIncomeLoss	62554000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.82
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.94
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.77
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16888000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16688000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16860000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16595000	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.94
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.64
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17132000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17142000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16860000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17187000	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	404000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	13723000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15876000	usd
	us-gaap	Net Income Loss NetIncomeLoss	62554000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	6000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-14000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-143000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-74000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	410000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13709000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16019000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	62480000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	821159000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-5515000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9044000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-114000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-15385000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	793192000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	604000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9499000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-35000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-895000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	802365000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	724000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12597000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	6000	usd
CY2022Q3	lgnd	Adjustments To Additional Paid In Capital Warrant And Bond Hedge Unwind Transactions AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions	202000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	404000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	816298000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	709525000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	20581000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8405000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-55000	usd
CY2021Q1	lgnd	Adjustments To Additional Paid In Capital Warrant And Bond Hedge Unwind Transactions AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions	396000	usd
CY2021Q1	lgnd	Adjustments To Additional Paid In Capital Reacquisition Of Equity Due To Debt Extinguishment Net Of Tax AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax	-11118000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	18106000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	745840000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1103000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10216000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-5000	usd
CY2021Q2	lgnd	Adjustments To Additional Paid In Capital Reacquisition Of Equity Due To Debt Extinguishment Net Of Tax AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax	-1362000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	30725000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	786517000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1898000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9754000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-14000	usd
CY2021Q3	lgnd	Adjustments To Additional Paid In Capital Reacquisition Of Equity Due To Debt Extinguishment Net Of Tax AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax	92000	usd
CY2021Q3	lgnd	Adjustments To Additional Paid In Capital Warrant And Bond Hedge Unwind Transactions AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions	96000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	13723000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	812066000	usd
	us-gaap	Profit Loss ProfitLoss	-15876000	usd
	us-gaap	Profit Loss ProfitLoss	62554000	usd
	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	1378000	usd
	lgnd	Non Cash Change In Estimated Fair Value Of Contingent Value Rights NonCashChangeInEstimatedFairValueOfContingentValueRights	39377000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	40399000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37902000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-75000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-145000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	639000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	12863000	usd
	lgnd	Amortization Of Commercial License And Other Economic Rights AmortizationOfCommercialLicenseAndOtherEconomicRights	-163000	usd
	lgnd	Amortization Of Commercial License And Other Economic Rights AmortizationOfCommercialLicenseAndOtherEconomicRights	96000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	4192000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7303000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	31140000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	28375000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	25570000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	8229000	usd
	lgnd	Gain Loss On Short Term Investments GainLossOnShortTermInvestments	-15709000	usd
	lgnd	Gain Loss On Short Term Investments GainLossOnShortTermInvestments	8135000	usd
	lgnd	Finance Lease And Operating Lease Right Of Use Asset Amortization FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization	4535000	usd
	lgnd	Finance Lease And Operating Lease Right Of Use Asset Amortization FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization	3349000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-45000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	658000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-20550000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8838000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10702000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3103000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-405000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3635000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	15111000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-4167000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-5182000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-20696000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1671000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	5909000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	84378000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	51156000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	39052000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	116898000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	202552000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	152465000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	24830000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	37100000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	750000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15792000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6566000	usd
	lgnd	Payments To Contingent Value Right Holders Investing Activity PaymentsToContingentValueRightHoldersInvestingActivity	960000	usd
	lgnd	Payments To Contingent Value Right Holders Investing Activity PaymentsToContingentValueRightHoldersInvestingActivity	0	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-80000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-135000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	170908000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	66236000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	260949000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	155760000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	42000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	9188000	usd
	us-gaap	Proceeds From Hedge Financing Activities ProceedsFromHedgeFinancingActivities	202000	usd
	us-gaap	Proceeds From Hedge Financing Activities ProceedsFromHedgeFinancingActivities	18938000	usd
	us-gaap	Payments For Hedge Financing Activities PaymentsForHedgeFinancingActivities	0	usd
	us-gaap	Payments For Hedge Financing Activities PaymentsForHedgeFinancingActivities	18446000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1831000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	29484000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6018000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5903000	usd
	lgnd	Payments To Contingent Value Right Holders Financing Activity PaymentsToContingentValueRightHoldersFinancingActivity	1545000	usd
	lgnd	Payments To Contingent Value Right Holders Financing Activity PaymentsToContingentValueRightHoldersFinancingActivity	1050000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-4171000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-270692000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-141925000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15406000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-24533000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19522000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47963000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4116000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23430000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1139000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1740000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	6630000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	3720000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3626000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	557000	usd
	lgnd	Accrued Inventory Purchases AccruedInventoryPurchases	7676000	usd
	lgnd	Accrued Inventory Purchases AccruedInventoryPurchases	4968000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-143000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-74000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, “long-term deferred revenue” has been added to the condensed consolidated balance sheet, separated from “other long-term liabilities” in our prior period presentation.</span></div>
CY2022Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4100000	usd
CY2021Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	7700000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	8800000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	22800000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66088000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64835000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169200000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	204660000	usd
CY2022Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	103544000	usd
CY2022Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	544000	usd
CY2022Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	5062000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	99026000	usd
CY2022Q3	lgnd	Debt Securities Available For Sale And Equity Securities Fvni DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI	117291000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	292225000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	842000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2370000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	290697000	usd
CY2021Q4	lgnd	Debt Securities Available For Sale And Equity Securities Fvni DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI	321586000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	8659000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	8458000	usd
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	982000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	939000	usd
CY2022Q3	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	9641000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	9397000	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	8	position
CY2022Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2022Q3	lgnd	Covid19 Accounts Receivable Allowance For Credit Loss Period Increase Decrease COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease	-100000	usd
	lgnd	Covid19 Accounts Receivable Allowance For Credit Loss Period Increase Decrease COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease	-300000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	181206000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	181206000	usd
CY2022Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	698231000	usd
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	732246000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	181206000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6229000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6532000	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2848000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2046000	usd
CY2022Q3	lgnd	Licensee Accrual Current LicenseeAccrualCurrent	4042000	usd
CY2021Q4	lgnd	Licensee Accrual Current LicenseeAccrualCurrent	630000	usd
CY2022Q3	lgnd	Returns Accrual ReturnsAccrual	0	usd
CY2021Q4	lgnd	Returns Accrual ReturnsAccrual	2420000	usd
CY2022Q3	lgnd	Accrued Asset Acquisitions Current AccruedAssetAcquisitionsCurrent	0	usd
CY2021Q4	lgnd	Accrued Asset Acquisitions Current AccruedAssetAcquisitionsCurrent	1000000	usd
CY2022Q3	lgnd	Accrued Subcontractor Expenses Current AccruedSubcontractorExpensesCurrent	1756000	usd
CY2021Q4	lgnd	Accrued Subcontractor Expenses Current AccruedSubcontractorExpensesCurrent	1759000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4463000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3192000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19338000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17579000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	12597000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	9754000	usd
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	31140000	usd
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	28375000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.028
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.029
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.029
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.005
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.005
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.48
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.61
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.61
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M24D
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y9M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16888000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16888000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16688000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16860000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16860000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16595000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16595000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	507000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17132000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17142000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16860000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17187000	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6706000	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5574000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6503000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6503000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4984000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4984000	shares
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	636000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	15706000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9139000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	66161000	usd
CY2010Q1	lgnd	Number Of Contingent Value Rights Series NumberOfContingentValueRightsSeries	4	contingent_value_right
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	reporting_unit
CY2021	lgnd	Payments To Unwind Warrants PaymentsToUnwindWarrants	18400000	usd
CY2021	lgnd	Proceeds From Unwinding Convertible Bond Hedges ProceedsFromUnwindingConvertibleBondHedges	18900000	usd
CY2021Q4	lgnd	Number Of Options Under Convertible Bond Hedges NumberOfOptionsUnderConvertibleBondHedges	598021	option
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	500000	usd
CY2022Q3	lgnd	Proceeds From Unwinding Convertible Bond Hedges ProceedsFromUnwindingConvertibleBondHedges	200000	usd
CY2022Q3	lgnd	Number Of Options Under Convertible Bond Hedges NumberOfOptionsUnderConvertibleBondHedges	370219	option
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	200000	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.529
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.101
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.203
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.151
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1700000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	102.23
CY2019Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	usd
CY2019Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P3Y
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	usd
CY2022Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	248800000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	32108000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16542000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	14444000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	16207000	usd
CY2022Q3	lgnd	Lease Right Of Use Asset LeaseRightOfUseAsset	46552000	usd
CY2021Q4	lgnd	Lease Right Of Use Asset LeaseRightOfUseAsset	32749000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2345000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2053000	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	48000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	46000	usd
CY2022Q3	lgnd	Lease Liability Current LeaseLiabilityCurrent	2393000	usd
CY2021Q4	lgnd	Lease Liability Current LeaseLiabilityCurrent	2099000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34893000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15494000	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	14000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	58000	usd
CY2022Q3	lgnd	Lease Liability LeaseLiability	37300000	usd
CY2021Q4	lgnd	Lease Liability LeaseLiability	17651000	usd
CY2022Q3	lgnd	Operating Leases Right Of Use Assets Increase Decrease OperatingLeasesRightOfUseAssetsIncreaseDecrease	8300000	usd
	lgnd	Operating Leases Right Of Use Assets Increase Decrease OperatingLeasesRightOfUseAssetsIncreaseDecrease	18400000	usd
CY2022Q3	lgnd	Operating Lease Liability Increase Decrease OperatingLeaseLiabilityIncreaseDecrease	8500000	usd
	lgnd	Operating Lease Liability Increase Decrease OperatingLeaseLiabilityIncreaseDecrease	21700000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1306000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4842000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4735000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4939000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5242000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5381000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	22317000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	48762000	usd
CY2022Q3	lgnd	Lessee Operating Lease Liability Tenant Improvement Allowance LesseeOperatingLeaseLiabilityTenantImprovementAllowance	1030000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10494000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	37238000	usd

Files In Submission

Name	View Source	Status
0000886163-22-000135-index-headers.html	Edgar Link	pending
0000886163-22-000135-index.html	Edgar Link	pending
0000886163-22-000135.txt	Edgar Link	pending
0000886163-22-000135-xbrl.zip	Edgar Link	pending
exhibit101-aremployeematte.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lgnd-20220930.htm	Edgar Link	pending
lgnd-20220930.xsd	Edgar Link	pending
lgnd-20220930_g1.jpg	Edgar Link	pending
lgnd_93022exhibit311.htm	Edgar Link	pending
lgnd_93022exhibit312.htm	Edgar Link	pending
lgnd_93022exhibit321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
lgnd-20220930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
lgnd-20220930_def.xml	Edgar Link	unprocessable
lgnd-20220930_lab.xml	Edgar Link	unprocessable
lgnd-20220930_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lgnd-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd

2022 Q4 Form 10-Q Financial Statement

#000088616322000135 Filed on November 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGND LIGAND PHARMACEUTICALS INC Stock $lgnd

2022 Q4 Form 10-Q Financial Statement

#000088616322000135 Filed on November 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGND
LIGAND PHARMACEUTICALS INC Stock $lgnd